4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it has given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its common stock from the Nasdaq Capital Market. The Company currently anticipates that it will file with the Securities and Exchange Commission (the "SEC") a Form 25, Notification of Removal of Listing and/or Registration Under Section 1

CARMEL, Ind., March 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health contract extension with a national healthcare organization. This agreement, combined with the previous year's agreement, brings the total contract value up to $1.32 million. "We are pleased to continue securing valuable population health contract extensions, as demonstrated by this announcement," said Dr. Deepika Vuppalanchi, C

2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind., March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind., March 4, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for its fourth quarter and full year 2024 ended December 31, 2024, on Tuesday, March 11, 2025, before the market opens. The company will host a conference call that same day, March 11, 2025, at 9:00 a.m. ET, to discuss the results.

CARMEL, Ind., Feb. 25, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a $450,000 contract extension with the Shelby County Health Department in Tennessee. The one-year contract extension enables Syra Health's team of epidemiologists and biostatisticians to continue uncovering disease trends and factors influencing disease while assessing their economic impact, as announced in February 2024. The project includes data analytics and the d

CARMEL, Ind., Feb. 18, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today positive preliminary results from the clinical research study being conducted by Indiana University (IU) of its flagship mental health product, Syrenity. A randomized clinical research study to test the efficacy of the Syrenity app is being led by Dr. Lorenzo-Luaces, principal investigator and associate department chair of Psychological and Brain Sciences at IU. Th

CARMEL, Ind., Feb. 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a six-month, $135,000 contract with a Midwest-based university to develop prevention-focused virtual training modules in behavioral health. Syra Health will collaborate with the university, its advisory committees, and subject matter experts to develop and implement the behavioral health training modules. The content will equip professionals with the skills necessary to ad

CARMEL, Ind., Jan. 7, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that the Washington D.C. government has awarded it a healthcare workforce contract, valued at up to $1 million, on behalf of the Office of the State Superintendent of Education. The Company also announced that the Indiana Family and Social Services Administration's NeuroDiagnostic Institute has increased its existing contract by $1.2 million, bringing the total value to $18.7 million.

- Now Available for Download on the App Store and Google Play Store. CARMEL, Ind., Dec. 2, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that its flagship mental health app, Syrenity, is now available for direct download by adults 18 years and older. Syrenity leverages a science-driven approach to address prevalent mental health challenges such as stress, anxiety, and depression, positioning the Company to capture growth opportuniti

CARMEL, Ind., Nov. 26, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today its participation in the Noble Financial Capital Markets 20th Annual Equity Conference, known as NobleCon20, taking place December 3-4 in Boca Raton, Florida. Syra Health CEO, Dr. Deepika Vuppalanchi, will present at the prestigious event, which highlights emerging growth companies. Dr. Vuppalanchi will deliver the Company's presentation on December 3 at 2:00 p.m.

8-K - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

10-K - Syra Health Corp (0001922335) (Filer)

EFFECT - Syra Health Corp (0001922335) (Filer)

S-3/A - Syra Health Corp (0001922335) (Filer)

S-3 - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

10-Q - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

4 - Syra Health Corp (0001922335) (Issuer)

SC 13G - Syra Health Corp (0001922335) (Subject)